医药板块速评（2022.01.28）_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":639703520,"tweetId":"639703520","gmtCreate":1643422394555,"gmtModify":1643422394555,"author":{"id":3452938437060827,"authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[{"themeId":"90198352d26c4d048ae2125fa23e95ae","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"2021年度盘点","type":3,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/discussion&rndata={\"themeId\":90198352d26c4d048ae2125fa23e95ae}&rnconfig={\"headerBarHidden\": true}","description":"2021的进度条已经走过了80%，想知道在过去的一年有哪些热点事件？最受虎友欢迎的股票是哪只？哪些文章是最受虎友们欢迎的？请来到我们的年度盘点主题，让我们一睹为快，细数即将过去的2021.","image":"https://static.tigerbbs.com/765900d46ef4c2f330116d6098992487"}],"images":[],"coverImages":[],"title":"医药板块速评（2022.01.28）","extraTitle":"","html":"<html><head></head><body>本期内容提示：1、CD47药物遇阻叠加催化剂荒漠，天境生物是否迎来长期配置区间？2、投资机构BVF逆势加仓小药企，是否有跟仓的机会？3、熊市中，抢反弹的利器有哪些？ <a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/03690\">$美团-W(03690)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BEKE\">$贝壳(BEKE)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>&nbsp;</body></html>","htmlText":"<html><head></head><body>本期内容提示：1、CD47药物遇阻叠加催化剂荒漠，天境生物是否迎来长期配置区间？2、投资机构BVF逆势加仓小药企，是否有跟仓的机会？3、熊市中，抢反弹的利器有哪些？ <a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/03690\">$美团-W(03690)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/BEKE\">$贝壳(BEKE)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>&nbsp;</body></html>","text":"本期内容提示： 1、CD47药物遇阻叠加催化剂荒漠，天境生物是否迎来长期配置区间？ 2、投资机构BVF逆势加仓小药企，是否有跟仓的机会？ 3、熊市中，抢反弹的利器有哪些？ $天境生物(IMAB)$ $美团-W(03690)$ $阿里巴巴(BABA)$ $贝壳(BEKE)$ $小米集团-W(01810)$","highlighted":1,"essential":1,"paper":2,"likeSize":2,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/639703520","repostId":0,"isVote":1,"tweetType":1,"viewCount":1442,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BABA","BEKE","03690","IMAB","01810"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":222,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":7218849,"gmtCreate":1643422413019,"gmtModify":1643423258529,"authorId":3452938437060827,"author":{"id":3452938437060827,"authorId":3452938437060827,"name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":639703520,"type":1,"supId":0,"prevId":0,"content":"更多信息，欢迎关注GZH：newnewtown ","text":"更多信息，欢迎关注GZH：newnewtown ","html":"更多信息，欢迎关注GZH：newnewtown ","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

医药板块速评（2022.01.28）

评论（1）

热议股票